tag financial 
STAT
MARCH 26, 2024
Troubled hospital operator Steward Health Care, grappling with a financial crisis that’s engulfed its eight Massachusetts hospitals, has moved to shore up its finances by striking a deal to sell its nationwide physician network to insurance giant UnitedHealth’s Optum Care unit. Continue to STAT+ to read the full story…
STAT
JANUARY 30, 2024
In response to concerns over multimillion-dollar price tags for new gene therapies for sickle cell disease, the U.S. million, respectively, and have raised alarms over the ability of financially strapped state Medicaid programs to absorb the expense. Two therapies recently approved by health regulators cost $2.2 million and $3.1
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 31, 2024
In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. Two therapies recently approved by health regulators cost $2.2 million and $3.1
PharmaShots
FEBRUARY 17, 2023
Iveric Bio Reports the US FDA Acceptance of NDA and Granted Priority Review of Avacincaptad Pegol for Geographic Atrophy Date: Feb 17, 2023 | Tags: Iveric Bio, Avacincaptad Pegol, Geographic Atrophy, Regulatory, US, FDA, NDA, Priority Review ALX Oncology Reports the First Patient Dosing of Evorpacept in the P-I Study (ASPEN-07) for the Treatment of (..)
pharmaphorum
AUGUST 17, 2020
The financial world, like the pharmaceutical industry, must operate within a tightly-defined regulatory environment, and in doing so has proved adept at connecting with its customers. Joanna: “Within the financial services sector ensuring consistency of content across different channels is happening at different scales.
STAT
AUGUST 2, 2023
The reimbursement cuts, along with restrictions that other employers are implementing, mark the financial downside of the drugs’ medical triumph. Besides the $26,500 annual price tag, treatment could cost U.S. The outlays are straining the finances of some plans, including those funded by employers. The
Pharmaceutical Technology
MAY 19, 2023
DMTs for MS have a high price tag, particularly in the US. The development and approval of safe and reliable curative therapies would be a major breakthrough in the treatment of MS, with considerable implications for patients’ financial circumstances and health-related quality of life.
Expert insights. Personalized for you.
139 
Let's personalize your content